@prefix dcterms: . @prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix RNA: . @prefix hgnc: . @prefix geneProductOf: . @prefix mesh: . @prefix occursIn: . @prefix species: . @prefix obo: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:2299; a RNA: . sub:_2 occursIn: mesh:D002467, obo:CL_0000576, obo:UBERON_0004237, species:9606; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject schem:Thiazolidinedione; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:Thiazolidinedione) -> r(HGNC:CPB1)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_3 dce:identifier "Recuration of TZD simulation"; dce:title "Recuration of TZD simulation"; dce:type "Other" . sub:_4 prov:value "Rosiglitazone increased carboxypeptidase B expression in both lep/lep and normal mice suggesting that this might be an independent effect of rosiglitazone that contributes to improved insulin processing. is translated to Activation of CPB1 (Homo sapiens) Gene Expression by Rosiglitazone"; prov:wasQuotedFrom sub:_3 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource sub:_3; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dcterms:created "2014-07-03T14:31:28.395+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }